Differential requirement for Hoxa9 in the development and differentiation of B, NK, and DC-lineage cells from Flt3+ multipotential progenitors
© Gwin et al.; licensee BioMed Central Ltd. 2013
Received: 16 October 2012
Accepted: 25 January 2013
Published: 30 January 2013
Hoxa9 is a homeodomain transcription factor important for the generation of Flt3+hiIL-7R- lymphoid biased-multipotential progenitors, Flt3+IL-7R+ common lymphoid progenitors (CLPs), and B cell precursors (BCP) in bone marrow (BM). In addition to B-cell, Flt3+IL-7R+ CLPs possess NK and DC developmental potentials, although DCs arise from Flt3+IL-7R- myeloid progenitors as well. In this study, we investigated the requirement for Hoxa9, from Flt3+ or Flt3- progenitor subsets, in the development of NK and DC lineage cells in BM. Flt3+IL-7R+Ly6D- CLPs and their Flt3+IL-7R+Ly6D+ B lineage-restricted progeny (BLP) were significantly reduced in hoxa9−/− mice. Interestingly, the reduction in Flt3+IL-7R+ CLPs in hoxa9−/− mice had no impact on the generation of NK precursor (NKP) subsets, the differentiation of NKP into mature NK cells, or NK homeostasis. Similarly, percentages and numbers of common dendritic progenitors (CDP), as well as their plasmacytoid or conventional dendritic cell progeny in hoxa9−/− mice were comparable to wildtype. These findings reveal distinct requirements for Hoxa9 or Hoxa9/Flt3 molecular circuits in regulation of B versus NK and DC development in BM.
KeywordsHoxa9 Flt3 IL-7R B-cell NK-cell DC Development
Cell fate decisions in the hematopoietic system are contingent upon the concerted activities of transcription factors that activate and/or repress lineage specific developmental programs and signaling molecules that regulate the temporal expression and activation status of lineage instructing regulatory proteins. Hoxa9 is a homeobox transcription factor with key roles in embryogenesis, hematopoiesis, and leukemogenesis. Hoxa9 is highly expressed in primitive blood cells in mouse and man, and downregulated as multipotent hematopoietic progenitors undergo lineage restriction and commitment[2–4]. The nonredundant role of Hoxa9 in hematopoietic progenitor biology has been determined through a variety of loss- and gain-of-function strategies. Hoxa9−/− mice are viable, but exhibit multiple hematopoietic defects including impaired recovery from hematopoietic stress, poor competitive reconstitution upon transplantation, impaired responses to lineage determining cytokines, and significant reductions in select LSK + subsets, myeloid precursor subsets, common lymphoid progenitors (CLP), thymic progenitors, and B cell precursors (BCP)[5–7]. Hoxa9 regulates the hematopoietic progenitor and BCP pool, in part, through transcriptional activation of the gene encoding Flt3. The Flt3 signaling pathway is critical for regulation of the hematopoietic progenitor pool and is essential at various stages for B, DC, and NK development and/or homeostasis[4, 8, 9].
Downregulation of c-kit, the receptor for the hematopoietic cytokine stem cell factor, accompanies lymphoid and DC lineage restriction from Flt3+hi LMPP[10–12]. Lin-c-kit+lo Flt3+ IL-7R+CLPs are a heterogeneous population that exhibit B, NK, T, and DC lineage differentiation potentials. Gene-targeted deletion of hoxa9 significantly reduces numbers of Flt3+ IL-7R+CLPs and BCP in BM[8, 13–15]. NKP are also the progeny of Flt3+ IL-7R+CLPs. Importantly, two independent groups using different experimental approaches recently showed that hematopoietic progenitors enriched for NK potential were IL-7R+, but Flt3-. In both studies, downregulation of Flt3 and upregulation of CD122 (IL-15Rα) were sequential steps in NK commitment from Flt3+ IL-7R+CLPs[16, 17]. CD122 is a critical component of the IL-15R complex and IL-15 signaling is essential for NK development. Lin-CD122+ NKP expressed high levels of Id2, a transcription factor important for NK differentiation. Flt3 signaling has been suggested to complement IL-15 in regulation of the BM NK cell pool as well as NK homeostasis in the spleen. At present, there is no information regarding the consequence of Hoxa9-deficiency, through Flt3-dependent or Flt3-independent regulatory circuits, on NK commitment, differentiation, or homeostasis.
Dendritic cells (DC) are essential innate immune effector cells. DCs are generated in BM from both the myeloid and lymphoid progenitor pathways. Common dendritic progenitors (CDPs) originate from Flt3+ myeloid progenitors that express Flt3+ but lack expression of the IL-7R. IL-7R+Flt3+ CLP primarily give rise to plasmacytoid DC. Flt3 signaling is essential in regulation of DC development in BM as well as DC homeostasis in the peripheral lymphoid organs[9, 12, 21]. The Ets-family transcription factor PU.1 regulates Flt3 in DCs. Interestingly, a recent study characterizing Hoxa9 target genes found many Hoxa9 binding sites were also bound by PU.1, notably flt3. Therefore, a molecular contribution of Hoxa9 to the development and/or homeostasis of DC lineage cells, merits further investigation.
The goal of this study was to examine the role of Hoxa9 in regulation of NK and DC development and differentiation. We found that, in contrast to B cells, Hoxa9 is largely dispensable for the development or peripheral homeostasis of NK or DC lineage cells. These findings uncover a distinct requirement for Hoxa9 in regulation of B versus NK and DC development from Flt3+ MPPs.
C57Bl6 mice (8–16 weeks of age) were purchased from The Jackson Laboratory (Bar Harbor, ME). Hoxa9−/− and flt3l−/− mice have been described and were bred and maintained at the Mayo Clinic animal facility and used between 8–16 weeks of age. All mice were aged matched in individual experiments and the experimental data did not vary as a function of age or sex. Bone marrow cells from individual male or female mice were collected from the four hind limb bones after carbon dioxide asphyxiation and single cell suspensions made in preparation for flow cytometric analysis. All experiments were carried out in accordance with Mayo Clinic Institutional Animal Care and Use Committee guidelines under Protocol A17509.
Antibodies and flow cytometry
Statistical significance was determined using the Student-t test and p-values less than 0.05 were considered significant.
Selective reduction in Flt3+IL-7R+, but not Flt3-IL-7R+CLPs in hoxa9−/− mice
We previously showed that Lin-c-kitloIL-7R+Flt3+ CLPs are significantly reduced in hoxa9−/− mice. Lin-c-kitloFlt3+ IL-7R+cells can be fractionated into Flt3+IL-7R+Ly6D- all lymphoid progenitors (ALP) and Flt3+IL-7R+Ly6D+B lineage restricted progenitors (BLP). Therefore, we employed this flow cytometric analysis to further define the lymphoid/B lineage developmental block in hoxa9−/− mice[4, 15]. The Lin+ cocktail used was extended to include antibodies to CD11c, NK1.1, and Ly6C to eliminate contamination of CLPs with mature NK1.1+ NK or CD11c/Ly6C + DCs. First, Lin-IL-7R+ cells within the lymphocyte light scatter gate (Figure1A) were gated for low expression of c-kit (Figure1B, gated region, middle panel). We note that using the extended Lin+ cocktail and gating on IL-7R+ cells, that overall percentages of Lin-IL-7R+ were not reduced in hoxa9−/− mice (0.71 ± 0.20% vs. 0.83 ± 0.29% in hoxa9−/− vs. wildtype, respectively, n = 5 mice). The Lin-IL-7R+c-kitlo subset was then fractionated into ALP and BLP using differential expression of Flt3 and Ly6D (Figure1B, bottom panels). This gating strategy revealed that ALP, as well as their B lineage restricted progeny BLP, are significantly reduced in hoxa9−/− mice, consistent with our previous findings. Precursor frequency analysis revealed that ALP represent 0.061 ± 0.013% vs. 0.024 ± 0.01% of BM cells within the lymphoid light scatter gate in B6 vs. hoxa9−/− mice, respectively (p = 0.0009). Similarly, BLP represent 0.026 ± 0.002% vs. 0.01 ± 0.002% of BM cells within the lymphoid light scatter gate in B6 vs. hoxa9−/− mice, respectively (p = 0.0005). Less BLP resulted in reductions in CD19+IgM- B cell precursors (11.5 ± 2% vs. 20.03 ± 2.0% of BM cells within the lymphoid light scatter gate, p = 0.0009, in hoxa9−/− vs. B6, respectively), consistent with our previous report[4, 15]. In contrast, a conspicuous population of IL-7R+Flt3-Ly6D- CLPs was not reduced (0.087 ± 0.22% vs. 0.11 ± 0.06% of BM cells within the lymphoid light scatter gate in B6 vs. hoxa9−/− mice, respectively, p = 0.11). Percentages of ALP, BLP, and IL-7R+Flt3-Ly6D- CLPs in B6 control and hoxa9−/− mice are summarized in Figure1C (data represents mean and SEM). We conclude from these flow cytometry analyses that Hoxa9-deficiency preferentially reduces Flt3+IL-7R+, but not Flt3-IL-7R+ CLP subsets.
NK development and differentiation in hoxa9−/− mice
CD27+ and CD244+ are cell surface markers expressed on IL-7R-Flt3+ multipotential progenitors (MPP) and CLPs, and maintained on mature NK cells[25, 26]. A small subset of CD27+CD244+IL-7R+ progenitors were identified in BM that lacked expression of surface markers displayed by lineage committed precursor subsets, including CD19, Mac1, Ly6D, NK1.1, and CD3. CD122 (IL-2Rβ) is a critical component of the IL-15R complex (comprised of IL-15Rα, IL-2Rγ and IL-2Rβ). Expression of the IL-15R is acquired as CLP differentiate into NK cells and is associated with loss of B, T, and DC lineage differentiation potentials. Fathman, et al., evaluated NK precursor potential in Lin- (CD19- Mac1- Ly6D- NK1.1- CD3-) CD27+CD244+IL-7R+ cells. Within the Lin-CD27+CD244+IL-7R+ subset, differential expression of Flt3 and CD122 distinguished three progenitor subsets, Flt3+CD122-, Flt3-CD122-, and Flt3-CD122+. Transplantation studies revealed that the Lin- CD27+CD244+ IL-7R+Flt3+ subset were found to functionally largely overlap CLPs, while the Lin-CD27+ and Lin-CD244+ subsets gave rise to NK cells. In vitro differentiation studies confirmed that the Lin-CD27+CD244+IL-7R+Flt3-CD122- and CD122+ subsets generated only NK cells. Based on differential expression of CD122 and the NK lineage bias exhibited by these cells in functional assays, the Lin-CD27+CD244+IL-7R+Flt3-CD122- subset was designated PreNKP and the Lin-CD27+CD244+IL-7R+Flt3-CD122+ subset rNKP. Previous studies showed that loss of Flt3-L significantly reduced the mature BM NK pool[9, 19]. However, a role for Hoxa9, through Flt3 dependent or independent mechanisms, in regulation of NK commitment and differentiation from the CLP stage has not been determined.
Flt3 signaling has been implicated in regulation of the mature BM NK compartment. Specifically, it was shown that mature Lin-CD122+NK1.1+Dx5+ NK cells are reduced in flt3l−/− mice and our results concur with those findings (Figure2D-E). Until the identification of NKP, BM NK transitional subsets were distinguished by differential expression of CD3ε, CD122, NK1.1, and CD49b/Dx5. To determine whether Hoxa9 regulates NK differentiation from NKP, BM cells from B6 wildtype, hoxa9−/−, and flt3−/− mice were stained with antibodies to CD3ε, CD122, NK1.1, and CD49b (Dx5). As shown in Figure2D-E, percentages and numbers of CD3ε-CD122+NK1.1-Dx5- NKP and CD3ε-CD122+NK1.1+Dx5- immature NK cells were similar between the 3 genotypes. These results suggest that Hoxa9 is dispensable for NK differentiation from rNKP. However, in contrast to Flt3 signaling, Hoxa9 is also dispensable for NK homeostasis in BM and spleen as neither mature NK cell frequencies nor numbers are reduced in BM or spleen in hoxa9−/− mice (Figure2D-G).
DC differentiation in hoxa9−/− mice
In this study we investigated the role of Hoxa9 in regulation of NK- and DC-lineage commitment and differentiation in BM. Hoxa9-deficient mice exhibit reductions in select hematopoietic progenitor subsets, including Flt3+ MPPs, Flt3+IL-7R+ CLPs, myeloid progenitor subsets, and BCPs, in addition to Pro-T subsets in the thymus[4, 15]. Hoxa9 regulates these hematopoietic progenitor subsets, at least in part, through transcriptional regulation of Flt3. Flt3 signaling is important for the development and/or maintenance of Flt3+ MPPs, CLPs, B, T, NK, and DC lineage cells[9, 19]. Previously, a role for Hoxa9, through Flt3-dependent or independent regulatory circuits, in regulation of NK- or DC-lineage commitment and differentiation in BM had not been established. Here we show that Hoxa9 is dispensable for the generation and differentiation of NK and DC lineage cells in BM. In contrast, Hoxa9 plays a non-redundant role in regulation of Flt3+IL-7R+ CLPs, as well as their Flt3+IL-7R+Ly6D+ B-lineage restricted progeny. Importantly, the reduction in Flt3+IL-7R+ CLPs in hoxa9−/− mice does not compromise the generation of NKP. These findings distinguish a critical function for Hoxa9 in Flt3+IL-7R+ CLPs in regulation of B, but not NK lineage commitment.
A recent fate mapping study of an IL-7R reporter mouse suggested that all NK-lineage cells progress through an IL-7R + stage. IL-7R + hematopoietic progenitors are generated in flt3−/− and flt3l−/− mice, albeit at reduced frequencies[8, 13]. Thus, Flt3 signaling is not essential for induction of IL-7R expression, consistent with our current findings. CD122 is upregulated in Flt3- CLPs uncoupling Flt3 signaling from induction of CD122 expression. PreNKP have been proposed to be developmentally positioned downstream of Flt3+ IL-7R+ CLPs (Figure5). We note that the few B220+ cells identified in FL−/− x IL-7Ra−/− mice are NK1.1+. Furthermore, il7−/− mice exhibit no deficiencies in NK cells in BM[19, 37]. These experimental results together with our findings herein suggest that commitment to the NK fate is not dependent on the combinatorial activities of Flt3 and/or IL-7R signaling or Hoxa9 function.
We show significantly reduced percentages of Flt3+IL-7R+ CLP/ALPs and Flt3+IL-7R+ BLPs in hoxa9−/− mice. The combinatorial activities of Flt3 and IL-7R signaling are indispensable for B cell genesis. IL-7R signaling in CLPs promotes the generation of BLP and their subsequent differentiation into BCP through Stat5-mediated induction of the B-cell fate determinant EBF[38, 39]. EBF in turn suppresses Id2 transcription[40, 41]. Id2 is critical for NK differentiation and transcript levels are increased in IL-7R+Flt3- rNKP[16, 42–44]. The observation that frequencies and numbers of PreNKP and rNKP are essentially unchanged while BLP are reduced suggest that Hoxa9, alone or in combination with Flt3 signaling, regulates a critical molecular circuitry that dictates the B vs. NK fate decision in Flt3+IL-7R+ CLP/ALPs.
Finally, the dramatic downregulation of Flt3 in PreNKP suggests that commitment to the NK fate might initiate a series of events that silences flt3 expression. Induction of the B lineage commitment factor Pax5 silences Flt3 transcription in committed BCP. Interestingly, failure to downregulate Flt3 impairs B cell differentiation. Ectopic expression studies examining the consequences of sustained expression of Flt3 or Hoxa9 on NK differentiation will be informative with regard to the requirement for regulated expression of Flt3 or Hoxa9 in NK development.
In summary, Hoxa9 is a critical regulator of early hematopoietic differentiation, in part through regulation of Flt3. We uncovered differential requirements for a Hoxa9 in the development/maintenance of IL-7R+Flt3+ CLPs and BLP. Although NKP and CDP share a common Lin-c-kitloFlt3+ progenitor with BLP, Hoxa9 is dispensable for their development and differentiation. These findings reinforce the stringent requirement for Hoxa9 in regulation of B lymphopoiesis and support future studies aimed at delineating Hoxa9-dependent genetic circuits that dictate the B cell fate decision.
Lineage negative Sca-1+ c-kit + hi
Lymphoid biased multipotential progenitor
Common lymphoid progenitor
All lymphoid progenitor
B cell precursor
Natural killer cell progenitor
Restricted natural killer cell progenitor
Common dendritic progenitor
Macrophage dendritic progenitor
The authors thank Dr. Virginia Smith Shapiro for helpful comments on the manuscript. K.L.M. is supported by R01HL096108 from the National Heart, Lung and Blood Institute.
- Abramovich C, Humphries RK: Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol. 2005, 12 (3): 210-216. 10.1097/01.moh.0000160737.52349.aa.View ArticlePubMedGoogle Scholar
- Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS, Largman C, Lawrence HJ, Humphries RK: Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci USA. 1994, 91 (25): 12223-12227. 10.1073/pnas.91.25.12223.PubMed CentralView ArticlePubMedGoogle Scholar
- So CW, Karsunky H, Wong P, Weissman IL, Cleary ML: Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. Blood. 2004, 103 (8): 3192-3199. 10.1182/blood-2003-10-3722.View ArticlePubMedGoogle Scholar
- Gwin K, Frank E, Bossou A, Medina KL: Hoxa9 regulates Flt3 in lymphohematopoietic progenitors. J Immunol. 2010, 185 (11): 6572-6583. 10.4049/jimmunol.0904203.PubMed CentralView ArticlePubMedGoogle Scholar
- Lawrence HJ, Christensen J, Fong S, Hu YL, Weissman I, Sauvageau G, Humphries RK, Largman C: Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood. 2005, 106 (12): 3988-3994. 10.1182/blood-2005-05-2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Lawrence HJ, Helgason CD, Sauvageau G, Fong S, Izon DJ, Humphries RK, Largman C: Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood. 1997, 89 (6): 1922-1930.PubMedGoogle Scholar
- Thorsteinsdottir U, Mamo A, Kroon E, Jerome L, Bijl J, Lawrence HJ, Humphries K, Sauvageau G: Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood. 2002, 99 (1): 121-129. 10.1182/blood.V99.1.121.View ArticlePubMedGoogle Scholar
- Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR: Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity. 1995, 3 (1): 147-161. 10.1016/1074-7613(95)90167-1.View ArticlePubMedGoogle Scholar
- McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, Maliszewski CR, Lynch DH, Smith J, Pulendran B, et al: Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood. 2000, 95 (11): 3489-3497.PubMedGoogle Scholar
- Kondo M, Weissman IL, Akashi K: Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997, 91 (5): 661-672. 10.1016/S0092-8674(00)80453-5.View ArticlePubMedGoogle Scholar
- Payne KJ, Medina KL, Kincade PW: Loss of c-kit accompanies B-lineage commitment and acquisition of CD45R by most murine B-lymphocyte precursors. Blood. 1999, 94 (2): 713-723.PubMedGoogle Scholar
- Onai N, Obata-Onai A, Schmid MA, Ohteki T, Jarrossay D, Manz MG: Identification of clonogenic common Flt3 + M-CSFR + plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol. 2007, 8 (11): 1207-1216. 10.1038/ni1518.View ArticlePubMedGoogle Scholar
- Dolence JJ, Gwin K, Frank E, Medina KL: Threshold levels of Flt3-ligand are required for the generation and survival of lymphoid progenitors and B-cell precursors. Eur J Immunol. 2011, 41 (2): 324-334. 10.1002/eji.201040710.PubMed CentralView ArticlePubMedGoogle Scholar
- Sitnicka E, Bryder D, Theilgaard-Monch K, Buza-Vidas N, Adolfsson J, Jacobsen SE: Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity. 2002, 17 (4): 463-472. 10.1016/S1074-7613(02)00419-3.View ArticlePubMedGoogle Scholar
- So CW, Karsunky H, Passegue E, Cozzio A, Weissman IL, Cleary ML: MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell. 2003, 3 (2): 161-171. 10.1016/S1535-6108(03)00019-9.View ArticlePubMedGoogle Scholar
- Carotta S, Pang SH, Nutt SL, Belz GT: Identification of the earliest NK-cell precursor in the mouse BM. Blood. 2011, 117 (20): 5449-5452. 10.1182/blood-2010-11-318956.View ArticlePubMedGoogle Scholar
- Fathman JW, Bhattacharya D, Inlay MA, Seita J, Karsunky H, Weissman IL: Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood. 2011, 118 (20): 5439-5447. 10.1182/blood-2011-04-348912.PubMed CentralView ArticlePubMedGoogle Scholar
- Puzanov IJ, Bennett M, Kumar V: IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J Immunol. 1996, 157 (10): 4282-4285.PubMedGoogle Scholar
- Cheng M, Charoudeh HN, Brodin P, Tang Y, Lakshmikanth T, Hoglund P, Jacobsen SE, Sitnicka E: Distinct and overlapping patterns of cytokine regulation of thymic and bone marrow-derived NK cell development. J Immunol. 2009, 182 (3): 1460-1468.View ArticlePubMedGoogle Scholar
- Sathe P, Vremec D, Wu L, Corcoran L, Shortman K: Convergent differentiation: myeloid and lymphoid pathways to murine plasmacytoid dendritic cells. Blood. 2013, 121 (1): 11-19. 10.1182/blood-2012-02-413336.View ArticlePubMedGoogle Scholar
- Waskow C, Liu K, Darrasse-Jeze G, Guermonprez P, Ginhoux F, Merad M, Shengelia T, Yao K, Nussenzweig M: The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol. 2008, 9 (6): 676-683. 10.1038/ni.1615.PubMed CentralView ArticlePubMedGoogle Scholar
- Carotta S, Dakic A, D'Amico A, Pang SH, Greig KT, Nutt SL, Wu L: The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity. 2010, 32 (5): 628-641. 10.1016/j.immuni.2010.05.005.View ArticlePubMedGoogle Scholar
- Huang Y, Sitwala K, Bronstein J, Sanders D, Dandekar M, Collins C, Robertson G, MacDonald J, Cezard T, Bilenky M, et al: Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood. 2012, 119 (2): 388-398. 10.1182/blood-2011-03-341081.PubMed CentralView ArticlePubMedGoogle Scholar
- Inlay MA, Bhattacharya D, Sahoo D, Serwold T, Seita J, Karsunky H, Plevritis SK, Dill DL, Weissman IL: Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. Genes Dev. 2009, 23 (20): 2376-2381. 10.1101/gad.1836009.PubMed CentralView ArticlePubMedGoogle Scholar
- Wiesmann A, Phillips RL, Mojica M, Pierce LJ, Searles AE, Spangrude GJ, Lemischka I: Expression of CD27 on murine hematopoietic stem and progenitor cells. Immunity. 2000, 12 (2): 193-199. 10.1016/S1074-7613(00)80172-7.View ArticlePubMedGoogle Scholar
- Kim S, Iizuka K, Kang HS, Dokun A, French AR, Greco S, Yokoyama WM: In vivo developmental stages in murine natural killer cell maturation. Nat Immunol. 2002, 3 (6): 523-528. 10.1038/ni796.View ArticlePubMedGoogle Scholar
- Budagian V, Bulanova E, Paus R, Bulfone-Paus S: IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 2006, 17 (4): 259-280. 10.1016/j.cytogfr.2006.05.001.View ArticlePubMedGoogle Scholar
- Rosmaraki EE, Douagi I, Roth C, Colucci F, Cumano A, Di Santo JP: Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol. 2001, 31 (6): 1900-1909. 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M.View ArticlePubMedGoogle Scholar
- Karsunky H, Merad M, Cozzio A, Weissman IL, Manz MG: Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med. 2003, 198 (2): 305-313. 10.1084/jem.20030323.PubMed CentralView ArticlePubMedGoogle Scholar
- Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman EG, Weissman IL: Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science (New York, NY. 2000, 290 (5499): 2152-2154. 10.1126/science.290.5499.2152.View ArticleGoogle Scholar
- Manz MG, Traver D, Miyamoto T, Weissman IL, Akashi K: Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood. 2001, 97 (11): 3333-3341. 10.1182/blood.V97.11.3333.View ArticlePubMedGoogle Scholar
- Belz GT, Nutt SL: Transcriptional programming of the dendritic cell network. Nat Rev Immunol. 2012, 12 (2): 101-113. 10.1038/nri3149.View ArticlePubMedGoogle Scholar
- Miller JC, Brown BD, Shay T, Gautier EL, Jojic V, Cohain A, Pandey G, Leboeuf M, Elpek KG, Helft J, et al: Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol. 2012, 13 (9): 888-899. 10.1038/ni.2370.PubMed CentralView ArticlePubMedGoogle Scholar
- Liu K, Victora GD, Schwickert TA, Guermonprez P, Meredith MM, Yao K, Chu FF, Randolph GJ, Rudensky AY, Nussenzweig M: In vivo analysis of dendritic cell development and homeostasis. Science (New York, NY. 2009, 324 (5925): 392-397.Google Scholar
- Schlenner SM, Madan V, Busch K, Tietz A, Laufle C, Costa C, Blum C, Fehling HJ, Rodewald HR: Fate mapping reveals separate origins of T cells and myeloid lineages in the thymus. Immunity. 2010, 32 (3): 426-436. 10.1016/j.immuni.2010.03.005.View ArticlePubMedGoogle Scholar
- Sitnicka E, Brakebusch C, Martensson IL, Svensson M, Agace WW, Sigvardsson M, Buza-Vidas N, Bryder D, Cilio CM, Ahlenius H, et al: Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis. J Exp Med. 2003, 198 (10): 1495-1506. 10.1084/jem.20031152.PubMed CentralView ArticlePubMedGoogle Scholar
- Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, Rosmaraki EE, Di Santo JP: Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol. 2005, 174 (3): 1213-1221.View ArticlePubMedGoogle Scholar
- Kikuchi K, Kasai H, Watanabe A, Lai AY, Kondo M: IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining early B cell factor expression. J Immunol. 2008, 181 (1): 383-392.PubMed CentralView ArticlePubMedGoogle Scholar
- Dias S, Silva H, Cumano A, Vieira P: Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors. J Exp Med. 2005, 201 (6): 971-979. 10.1084/jem.20042393.PubMed CentralView ArticlePubMedGoogle Scholar
- Pongubala JM, Northrup DL, Lancki DW, Medina KL, Treiber T, Bertolino E, Thomas M, Grosschedl R, Allman D, Singh H: Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat Immunol. 2008, 9 (2): 203-215. 10.1038/ni1555.View ArticlePubMedGoogle Scholar
- Thal MA, Carvalho TL, He T, Kim HG, Gao H, Hagman J, Klug CA: Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage. Proc Natl Acad Sci USA. 2009, 106 (2): 552-557. 10.1073/pnas.0802550106.PubMed CentralView ArticlePubMedGoogle Scholar
- Boos MD, Yokota Y, Eberl G, Kee BL: Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J Exp Med. 2007, 204 (5): 1119-1130. 10.1084/jem.20061959.PubMed CentralView ArticlePubMedGoogle Scholar
- Ikawa T, Fujimoto S, Kawamoto H, Katsura Y, Yokota Y: Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc Natl Acad Sci USA. 2001, 98 (9): 5164-5169. 10.1073/pnas.091537598.PubMed CentralView ArticlePubMedGoogle Scholar
- Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, Nishikawa S, Gruss P: Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 1999, 397 (6721): 702-706. 10.1038/17812.View ArticlePubMedGoogle Scholar
- Holmes ML, Carotta S, Corcoran LM, Nutt SL: Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment. Genes Dev. 2006, 20 (8): 933-938. 10.1101/gad.1396206.PubMed CentralView ArticlePubMedGoogle Scholar
- Lai AY, Lin SM, Kondo M: Heterogeneity of Flt3-expressing multipotent progenitors in mouse bone marrow. J Immunol. 2005, 175 (8): 5016-5023.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.